Bayer Covenants Not To Sue, Still Has Headache - Patent : co

Bayer's ‘053 patent on its drug Xarelto® expires in November 2024, and Bayer granted Mylan a covenant not to sue. Bayer has a second patent that is subject to a pediatric exclusivity that expires later.

Related Keywords

Caraco Pharm , , Judge Hatcher , Orange Book Listed , Federal Circuit , Mondaq , Bayer Covenants Not To Sue , Till Has Headache , Intellectual Property , Patent ,